Amgen Builds Up Future Launches As Oncology Biosimilars Slide

Firm Looks To Amjevita, Along With Stelara And Eylea Rivals, For Future Growth

Wooden businessman down up stairs
As Amgen’s oncology biosimilars decline, a lift will come from new products • Source: Shutterstock

More from Biosimilars

More from Products